OXFORD, England--(BUSINESS WIRE)--Oct 18, 2023--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch庐 3D genomics platform and Bupa, the UK蘑菇视频 leading health insurer, announce a strategic agreement to give Bupa ...
LEWISVILLE, Texas--(BUSINESS WIRE)--Oct 18, 2023--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023 after market close. The Company will host a ...
TORONTO--(BUSINESS WIRE)--Oct 18, 2023--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the initiation of the ...
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct 18, 2023--Cessation Therapeutics, Inc. (鈥淐essation), a clinical-stage biotechnology company advancing biologics that target substances of abuse, today announced that it has been awarded an additional grant from the National Institute on Drug Abuse ...
TOKYO--(BUSINESS WIRE)--Oct 18, 2023--Harshavardhan Sai Sadineni and Srived Meda of Kasturba Medical College, Manipal, India, won the XVIII Fujio Cup Quiz (FCQ) on Stem cells and Regenerative medicine (RM) in the NCRM NICHE 2023; Sri Ramachandra Institute for Higher Education and Research, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 18, 2023--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the primary analysis of the Phase III ALINA study demonstrating a statistically significant and clinically meaningful improvement in ...
